Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guangdong Marubi Biotechnology CoSHSE:603983 +2.14%71 Pretax Margin % is 13.98% as of Mar. 2026, which is 30% below its 10-year median of 19.99. GuruFocus rates SHSE:603983 with a GF Score™ of 71/100 and a GF Value™ of ¥45.12 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,955 Consumer Packaged Goods companies, Guangdong Marubi Biotechnology Co ranks better than 62.61% on this metric.
The historical rank and industry rank for Guangdong Marubi Biotechnology Co's Pretax Margin % or its related term are showing as below:
SHSE:603983'
s Pretax Margin % Range Over the Past 10 Years
Min: 7.24 Med: 19.99 Max: 34.1
Current: 7.24
SHSE:603983's Pretax Margin % is ranked better than 62.61% of 1955
companies
in the Consumer Packaged Goods industry
Industry Median: 4.69
vs SHSE:603983: 7.24
Guangdong Marubi Biotechnology Co (SHSE:603983) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Guangdong Marubi Biotechnology Co Pretax Margin % Related Terms
Guangdong Marubi Biotechnology Co Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Marubi Biotechnology Co Pretax Margin % Chart
SHSE:603983 vs PG, CL, KVUE: Pretax Margin % Comparison
For the Household & Personal Products subindustry, Guangdong Marubi Biotechnology Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Marubi Biotechnology Co Pretax Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Guangdong Marubi Biotechnology Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Guangdong Marubi Biotechnology Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Marubi Biotechnology Co (SHSE:603983) has a Pretax Margin % of 13.98% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Guangdong Marubi Biotechnology Co and its competitors. This is 30% below median its historical median of 19.99. Over the past decade, Guangdong Marubi Biotechnology Co's Pretax Margin % has ranged from 7.24 to 34.10. According to the industry distribution chart, Guangdong Marubi Biotechnology Co ranks #731 out of 1955 companies in the Consumer Packaged Goods industry, placing it in the top 37.4%.
Is Guangdong Marubi Biotechnology Co's Pretax Margin % too high?
Guangdong Marubi Biotechnology Co's current Pretax Margin % of 13.98% is 30% below median its 10-year median of 19.99. Over the past 10 years, this metric has ranged from a low of 7.24 to a high of 34.10. The Consumer Packaged Goods industry median Pretax Margin % is 4.69. Guangdong Marubi Biotechnology Co's value of 13.98% is 198.1% above this industry median. Based on the distribution chart, Guangdong Marubi Biotechnology Co ranks #731 out of 1955 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Guangdong Marubi Biotechnology Co has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangdong Marubi Biotechnology Co's Pretax Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Guangdong Marubi Biotechnology Co ranks #731 out of 1955 companies for Pretax Margin %. This puts Guangdong Marubi Biotechnology Co in the upper half of its industry. The industry median Pretax Margin % is 4.69. Guangdong Marubi Biotechnology Co's value of 13.98% is 198.1% above this benchmark. Historically, Guangdong Marubi Biotechnology Co's own Pretax Margin % has ranged from 7.24 to 34.10 over the past decade. While the company's 10-year median is 19.99 vs. the industry median of 4.69, Guangdong Marubi Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Consumer Packaged Goods company?
The median Pretax Margin % among Consumer Packaged Goods companies is 4.69, based on 1,955 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangdong Marubi Biotechnology Co's current Pretax Margin % of 13.98% is 198.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Guangdong Marubi Biotechnology Co and its competitors. For the Consumer Packaged Goods industry, the median Pretax Margin % is 4.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangdong Marubi Biotechnology Co's current Pretax Margin % is 13.98%, which is 30% below median its own 10-year median of 19.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Marubi Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Guangdong Marubi Biotechnology Co (SHSE:603983) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥45.12, compared to a current price of ¥28.67 — trading 36.5% below its estimated fair value. The current Pretax Margin % is 13.98%, which is 30% below median its 10-year median of 19.99 and 198.1% above the Consumer Packaged Goods industry median of 4.69. Guangdong Marubi Biotechnology Co's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Guangdong Marubi Biotechnology Co (SHSE:603983), the current Pretax Margin % is 13.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangdong Marubi Biotechnology Co (SHSE:603983) Overvalued in 2026?
Based on GuruFocus' analysis, Guangdong Marubi Biotechnology Co stock appears to be undervalued.
The current stock price of ¥28.67 is trading 36.5% below its estimated GF Value™ of ¥45.12.
GuruFocus considers Guangdong Marubi Biotechnology Co to be Significantly Undervalued.
Key valuation signals for SHSE:603983:
Pretax Margin %: 13.98% (30% below median its 10-year median of 19.99)
GF Value™: ¥45.12 vs. price of ¥28.67 (36.5% below fair value)
Industry Position: 198.1% above the Consumer Packaged Goods median (#731 of 1955)
No single metric tells the full story. See the SHSE:603983 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603983 has been successfully added to your 
